Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Carotid revascularization · Montana | Carotid revascularization · California | |
|---|---|---|
| Surgeons, 2024 | 4 | 46 |
| Medicare fee-for-service cases | 162 | 2,550 |
| Growth since 2019 (Medicare FFS) | −1.2%/yr | −2.4%/yr |
| Forecast cases (Medicare FFS) | 170 in 2030 | 2,560 in 2030 |
| Forecast growth | +1.3%/yr to 2030 | +0.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.8 | 0.7 |
| Medicare Advantage share | 32% | 56% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 41 | 55 |
| Top 10 surgeons' share | 100% | 42% |
| Surgeons growing | 0 | 3 |
| New since the base year | 1 | 11 |
| Likely to stop billing it | 2 by 2026 | 20 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $383 | $3,386 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.